BONST
CORV

Bank of Nova Scotia Trust’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bank of Nova Scotia Trust’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10
Closed – – 437
2017
Q3 		$0 Buy
+10
New +$34 ﹤0.01% 473

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Bank of Nova Scotia Trust's CORV Position: Q4 2017 in Review

Bank of Nova Scotia Trust sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2017, closing a stake of 10 shares.

Bank of Nova Scotia Trust first reported a position in CORV in Q3 2017 and held it in 1 quarter. The position peaked at $0 in Q3 2017. 27 funds tracked by Wall St. Rank hold CORV as of Q4 2017.

  • Bank of Nova Scotia Trust reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2017 after selling out during the quarter.
  • Bank of Nova Scotia Trust sold 10 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2017.
  • Bank of Nova Scotia Trust first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2017 and held it in 1 quarter.
  • Bank of Nova Scotia Trust's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $0 in Q3 2017.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2017.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2017, filed 13 Feb 2018.